The role of Endocan as a Prognostic Biomarker in community-acquired pneumonia

dc.contributor.author	Kucuk, Mehmet
dc.contributor.author	Gunaydin, Şenay
dc.contributor.author	GÜNAYDIN, ULUĞ MUTLU
dc.date.accessioned	2021-03-04T13:44:46Z
dc.date.available	2021-03-04T13:44:46Z
dc.date.issued	2019
dc.identifier.citation	Gunaydin Ş., Kucuk M., GÜNAYDIN U. M. , "The role of Endocan as a Prognostic Biomarker in community-acquired pneumonia", PAKISTAN JOURNAL OF MEDICAL SCIENCES, cilt.35, sa.1, ss.117-123, 2019
dc.identifier.issn	1682-024X
dc.identifier.other	vv_1032021
dc.identifier.other	av_7e08ea43-cbd0-47da-9d4b-2664a95706f5
dc.identifier.uri	http://hdl.handle.net/20.500.12627/86081
dc.identifier.uri	https://doi.org/10.12669/pjms.35.1.280
dc.description.abstract	Objective: The aim of this study was to determine the importance of using endocan as a biomarker in deciding the setting of treatment and predicting prognosis in patients with community-acquired pneumonia (CAP).
dc.language.iso	eng
dc.subject	Klinik Tıp (MED)
dc.subject	TIP, GENEL & İÇECEK
dc.subject	Klinik Tıp
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Temel Tıp Bilimleri
dc.title	The role of Endocan as a Prognostic Biomarker in community-acquired pneumonia
dc.type	Makale
dc.relation.journal	PAKISTAN JOURNAL OF MEDICAL SCIENCES
dc.contributor.department	İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume	35
dc.identifier.issue	1
dc.identifier.startpage	117
dc.identifier.endpage	123
dc.contributor.firstauthorID	2216284

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.